Dear Doctor Demirkazik,
It was a pleasure to meet you during the ESMO National Representatives Meetings in Zurich on May 1.
This time, please allow me to approach you with a BIG request:
As you might have heard, I have been nominated by ESMO as one of two candidates for the ESMO presidency 2018-2019. Having in mind the concept of "ONE EUROPE - ONE VISION" assuring cancer diagnosis and treatment of the best quality to be delivered throughout Europe, I would want ESMO to adopt this program should I be elected president.
I am sure that considering what we were discussing during our meeting, this would very much fit into the concept of all of us. I, therefore, would very much ask for your support and the one of Turkish ESMO members for my bid for the presidency. This will be done via the ESMO homepage during the first two weeks of June.
I would truly very much appreciate your help and support!
Very warm regards and many thanks!
Yours,
Christoph Zielinski
Univ. Professor Dr. Dr.h.c. Christoph Zielinski
Chairman, Clinical Division of Oncology and Department of Medicine I,
Chairman, Comprehensive Cancer Center
Medical University Vienna - General Hospital
Vienna, Austria
Dear Ahmet,
It is a great honor for me to stand as candidate in the forthcoming ESMO President Election for the 2018 – 2019 term. In the hope that you will support me in my campaign, please find enclosed an e-flyer underlining what I believe to be my key strengths in running for ESMO President, my overarching vision for our Society, as well as my Action Plan Overview - point by point. Please note: more detailed information as well as my full letter of intent can be found on ESMO´s website at: www.esmo.org.
The voting process could not be simpler and, on behalf of ESMO, I very much hope that an even greater number of ESMO Members will be keen to have their say this year and register their interest by voting for their preferred candidate. You can cast your vote by either visiting ESMO´s Booth during this year´s ASCO meeting, or elect online via ESMO´s website (www.esmo.org) from 01 June – 15 June, 2015.
With my personal thanks in advance for taking a few moments to read and consider the e-flyer enclosed,
Josep
Josep Tabernero, MD PhD
Head, Medical Oncology Department
Vall d'Hebron University Hospital
Vall d'Hebron Institute of Oncology (VHIO) P. Vall d'Hebron 119-129
08035 Barcelona SPAIN
Tel +34 93 489 4301
Fax +34 93 274 6059
saglik/userfiles/file/ESMO%20Zielinski.pdf
saglik/userfiles/file/esmo-Tabarnero.pdf